Detalles de la búsqueda
1.
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
Br J Cancer
; 130(6): 941-950, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38245661
2.
Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: association with treatment outcomes.
Int J Gynecol Cancer
; 33(9): 1427-1433, 2023 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37541687
3.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690073
4.
In Silico Study to Predict the Structural and Functional Consequences of SNPs on Biomarkers of Ovarian Cancer (OC) and BPA Exposure-Associated OC.
Int J Mol Sci
; 23(3)2022 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35163645
5.
Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 277-288, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33357510
6.
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial.
Gynecol Oncol
; 163(1): 72-78, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34412908
7.
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.
Gynecol Oncol
; 161(2): 502-507, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33612336
8.
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
Lancet Oncol
; 21(7): 969-977, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32615110
9.
Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours.
Br J Cancer
; 122(4): 483-490, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31813938
10.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet
; 394(10214): 2084-2095, 2019 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791688
11.
Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial.
Gynecol Oncol
; 156(3): 545-551, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932108
12.
Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors.
Int J Gynecol Cancer
; 30(7): 1026-1033, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321768
13.
Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study.
Int J Gynecol Cancer
; 30(2): 213-220, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31780570
14.
Neoadjuvant Chemotherapy without Radiation in Colorectal Cancer.
Clin Colon Rectal Surg
; 33(5): 287-297, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32968364
15.
Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.
Radiology
; 293(2): 374-383, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31573402
16.
Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome.
Ann Surg Oncol
; 26(9): 2943-2951, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31243666
17.
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.
Gynecol Oncol
; 154(1): 29-37, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31130288
18.
Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers.
Carcinogenesis
; 39(3): 407-417, 2018 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29126163
19.
Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer.
Int J Gynecol Cancer
; 27(6): 1118-1122, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28333841
20.
Surgery for Recurrent Uterine Cancer: Surgical Outcomes and Implications for Survival-A Case Series.
Int J Gynecol Cancer
; 27(4): 759-767, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28338493